Last reviewed · How we verify
NCT05650359
Study of the Use of Orthopulse Photobiomodulation
NA trial testing OrthoPulse in Orthodontics in 42 participants. Currently enrolling.
15 May 2028
Quick facts
| Lead sponsor | Biolux Technology GmbH |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 13 October 2022 |
| Primary completion | 15 May 2028 |
| Estimated completion | 15 May 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- OrthoPulse
- No intervention
Conditions studied
- Orthodontics — all drugs for Orthodontics →
Sponsor
Biolux Technology GmbH
Who can join
18 and older, any sex, with Orthodontics. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This PMCF study evaluates the safety and performance of OrthoPulse photobiomodulation to accelerate tooth movement during alignment with fixed appliances.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05650359
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Orthodontics
Currently open trials in the same condition.
- NCT06948162 — Exploration of the Utility of Dental-dedicated MRI for Dentistry · recruiting
- NCT06199674 — Effects of PBM on Fixed-appliance Orthodontic Patients · NA · recruiting
- NCT03967002 — Treatment of the Mandibular Dental Crowding With and Without Corticotomy Surgery · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05650359 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biolux Technology GmbH
- Last refreshed: 7 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05650359.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing